Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2025-12-24 @ 4:48 PM
NCT ID:
NCT02553850
Eligibility Criteria:
Inclusion Criteria:
* All criteria in accordance with the Summary of Product Characteristics of Bondronat (ibandronate)
* Adult patients greater than (\>) 18 years of age
* Histologically confirmed breast cancer
* Confirmed bone metastasis (by bone scintigraphy, X-ray, computed tomography or magnetic resonance imaging)
* Life expectancy \>6 months
* No previous bisphosphonate therapy
* Patients signed written informed consent form before study start
Exclusion Criteria:
* All criteria in accordance with the Summary of Product Characteristics of Bondronat(ibandronate)
* Hypersensitivity to the active substance or any of the excipients of Bondronat (ibandronate)
* Hypersensitivity to bisphosphonates
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02553850
Study Brief:
Protocol Section:
NCT02553850